Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Pneumologie (Stuttgart, Germany)|October 18, 2022
[A cross-sectional study in three German hospitals regarding oxygen therapy characteristics]Oana Joean, Maria Petronella Vanʼt Klooster, Moritz Z Kayser, et al.
Deutsche Medizinische Wochenschrift (1946)|July 22, 2022
[A cross-sectional study in three German hospitals regarding oxygen therapy characteristics]Oana Joean, Maria Petronella Vanʼt Klooster, Moritz Z Kayser, et al.
Lung Cancer (Amsterdam, Netherlands)|November 19, 2022
NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapyArne Trummer, Andre Bethge, Nicolas Dickgreber, et al.
Journal of Oncology|December 31, 2020
Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor TherapyNora Möhn, Susann Mahjoub, Ralf Gutzmer, et al.
Thrombosis and Haemostasis|September 30, 2003
Circulating endothelial cells in pulmonary hypertensionTodd M Bull, Heiko Golpon, Robert P Hebbel, et al.
Oncology Research and Treatment|April 9, 2020
Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver AlterationsDiego Kauffmann-Guerrero, Amanda Tufman, Kathrin Kahnert, et al.
European Heart Journal|July 6, 2010
Circulating angiopoietins in idiopathic pulmonary arterial hypertensionPhilipp Kümpers, Nils Nickel, Alexander Lukasz, et al.
Circulation Research|April 26, 2003
Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growthShingo Ameshima, Heiko Golpon, Carlyne D Cool, et al.
BMC Medical Imaging|December 5, 2022
Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification: higher contrast uptake associated with response and better prognosisStephan Rheinheimer, Petros Christopoulos, Stella Erdmann, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2010
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapyHossein A Ghofrani, Nicholas W Morrell, Marius M Hoeper, et al.
Pageof 4